JP2018520170A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520170A5
JP2018520170A5 JP2018500737A JP2018500737A JP2018520170A5 JP 2018520170 A5 JP2018520170 A5 JP 2018520170A5 JP 2018500737 A JP2018500737 A JP 2018500737A JP 2018500737 A JP2018500737 A JP 2018500737A JP 2018520170 A5 JP2018520170 A5 JP 2018520170A5
Authority
JP
Japan
Prior art keywords
pyrrolo
pyridin
ethanone
methyl
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018500737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018520170A (ja
JP6964576B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/041339 external-priority patent/WO2017007938A1/en
Publication of JP2018520170A publication Critical patent/JP2018520170A/ja
Publication of JP2018520170A5 publication Critical patent/JP2018520170A5/ja
Priority to JP2021138906A priority Critical patent/JP7369743B2/ja
Application granted granted Critical
Publication of JP6964576B2 publication Critical patent/JP6964576B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018500737A 2015-07-09 2016-07-07 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用 Active JP6964576B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021138906A JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562190416P 2015-07-09 2015-07-09
US62/190,416 2015-07-09
PCT/US2016/041339 WO2017007938A1 (en) 2015-07-09 2016-07-07 Substituted 4-azaindoles and their use as glun2b receptor modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021138906A Division JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Publications (3)

Publication Number Publication Date
JP2018520170A JP2018520170A (ja) 2018-07-26
JP2018520170A5 true JP2018520170A5 (https=) 2019-07-25
JP6964576B2 JP6964576B2 (ja) 2021-11-10

Family

ID=56497884

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018500737A Active JP6964576B2 (ja) 2015-07-09 2016-07-07 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用
JP2021138906A Active JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021138906A Active JP7369743B2 (ja) 2015-07-09 2021-08-27 置換4-アザインドール及びglun2b受容体調節因子としてのそれらの使用

Country Status (25)

Country Link
US (2) US9963447B2 (https=)
EP (1) EP3319963B1 (https=)
JP (2) JP6964576B2 (https=)
KR (1) KR20180026760A (https=)
CN (1) CN108026094B (https=)
AU (1) AU2016291158B2 (https=)
BR (1) BR112018000468A2 (https=)
CA (1) CA2991765C (https=)
CY (1) CY1123007T1 (https=)
DK (1) DK3319963T3 (https=)
EA (1) EA033197B1 (https=)
ES (1) ES2781867T3 (https=)
HR (1) HRP20200410T1 (https=)
HU (1) HUE047460T2 (https=)
IL (1) IL256758A (https=)
LT (1) LT3319963T (https=)
MA (1) MA42397B1 (https=)
MD (1) MD3319963T2 (https=)
MX (1) MX2018000352A (https=)
PL (1) PL3319963T3 (https=)
PT (1) PT3319963T (https=)
SI (1) SI3319963T1 (https=)
SM (1) SMT202000134T1 (https=)
WO (1) WO2017007938A1 (https=)
ZA (1) ZA201800827B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016025917A1 (en) 2014-08-15 2016-02-18 Janssen Pharmaceuticals, Inc. Triazoles as nr2b receptor inhibitors
ES2791252T3 (es) 2014-08-15 2020-11-03 Janssen Pharmaceuticals Inc Pirazoles
HRP20200410T1 (hr) 2015-07-09 2020-08-21 Janssen Pharmaceutica Nv Supstituirani 4-azaindoli i njihova upotreba kao modulatora glun2b receptora
BR112018016329A2 (pt) 2016-02-10 2018-12-18 Janssen Pharmaceutica Nv 1,2,3-triazóis substituídos como moduladores de nmda seletivos para nr2b
TW201819376A (zh) 2016-10-06 2018-06-01 比利時商健生藥品公司 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途
WO2019193516A2 (en) 2018-04-04 2019-10-10 Janssen Pharmaceutica Nv Substituted pyridine and pyrimidines and their use as glun2b receptor modulators
CN113993868A (zh) * 2019-06-14 2022-01-28 詹森药业有限公司 取代的吡唑并吡啶酰胺以及它们作为glun2b受体调节剂的用途
KR20220024403A (ko) * 2019-06-14 2022-03-03 얀센 파마슈티카 엔.브이. 치환된 피라졸로-피라진 및 이들의 glun2b 수용체 조절제로서의 용도
MX2021015508A (es) 2019-06-14 2022-01-31 Janssen Pharmaceutica Nv Carbamatos de piridina y su uso como moduladores del receptor glun2b.
CN113950357A (zh) 2019-06-14 2022-01-18 詹森药业有限公司 吡嗪氨基甲酸酯及其作为GluN2B受体调节剂的用途
SG11202112405VA (en) 2019-06-14 2021-12-30 Janssen Pharmaceutica Nv Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulators
AU2020293642A1 (en) 2019-06-14 2022-01-20 Janssen Pharmaceutica Nv Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators
JP7667097B2 (ja) * 2019-06-14 2025-04-22 ヤンセン ファーマシューティカ エヌ.ベー. 置換ピラゾロ-ピリジンアミド及びglun2b受容体調節因子としてのその使用
CN114621125B (zh) * 2020-12-14 2024-07-09 中国科学技术大学 Nlrp3炎症小体抑制剂及其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1490364B1 (en) * 2002-03-28 2007-09-26 Eisai R&D Management Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
EP1720860A1 (en) 2004-02-18 2006-11-15 AstraZeneca AB Triazole compounds and their use as metabotropic glutamate receptor antagonists
US20060183758A1 (en) * 2005-02-17 2006-08-17 Cb Research And Development, Inc. Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans
US7807704B2 (en) * 2006-03-30 2010-10-05 Chemocentryx, Inc. Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
PE20090717A1 (es) * 2007-05-18 2009-07-18 Smithkline Beecham Corp Derivados de quinolina como inhibidores de la pi3 quinasa
TWI443090B (zh) 2007-05-25 2014-07-01 Abbvie Deutschland 作為代謝性麩胺酸受體2(mglu2 受體)之正向調節劑之雜環化合物
US20100325949A1 (en) 2007-07-03 2010-12-30 Edward Scott Carlson Support apparatus for climbing plants
CN101842357A (zh) 2007-08-30 2010-09-22 武田药品工业株式会社 取代的吡唑衍生物
EP2215073A4 (en) 2007-10-31 2011-04-06 Merck Sharp & Dohme SLEEP MODULATION WITH NR2B RECEPTOR ANTAGONISTS
WO2009118187A1 (en) 2008-03-27 2009-10-01 Evotec Neurosciences Gmbh Methods for treating disorders using nmda nr2b-subtype selective antagonist
NZ590688A (en) 2008-08-05 2012-09-28 Daiichi Sankyo Co Ltd imidazo[4,5-b]pyridin-2-one derivatives
RU2517181C2 (ru) * 2008-10-16 2014-05-27 Орто-Макнейл-Янссен Фармасьютикалз, Инк. Производные индола и бензоморфолина в качестве модулятора метаботропных глутаматных рецепторов
CA2744498C (en) 2008-11-25 2017-10-24 University Of Rochester Mlk inhibitors and methods of use
TWI491606B (zh) * 2009-07-13 2015-07-11 Gilead Sciences Inc 調節細胞凋亡信號之激酶的抑制劑
EP2579717A4 (en) 2010-06-09 2013-12-11 Merck Sharp & Dohme POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
WO2013130855A1 (en) 2012-03-02 2013-09-06 Takeda Pharmaceutical Company Limited Indazole derivatives
WO2014124651A1 (en) * 2013-02-15 2014-08-21 Københavns Universitet Pyrrolidine-2-carboxylic acid derivatives as iglur antagonists
TW201444820A (zh) * 2013-03-13 2014-12-01 Abbvie Inc 吡啶cdk9激酶抑制劑
SG11201506687RA (en) * 2013-03-15 2015-09-29 Plexxikon Inc Heterocyclic compounds and uses thereof
CN103626767A (zh) * 2013-12-04 2014-03-12 上海药明康德新药开发有限公司 区域选择性的氮杂吲哚及其合成方法
ES2791252T3 (es) 2014-08-15 2020-11-03 Janssen Pharmaceuticals Inc Pirazoles
WO2016025917A1 (en) 2014-08-15 2016-02-18 Janssen Pharmaceuticals, Inc. Triazoles as nr2b receptor inhibitors
HRP20200410T1 (hr) 2015-07-09 2020-08-21 Janssen Pharmaceutica Nv Supstituirani 4-azaindoli i njihova upotreba kao modulatora glun2b receptora
BR112018016329A2 (pt) 2016-02-10 2018-12-18 Janssen Pharmaceutica Nv 1,2,3-triazóis substituídos como moduladores de nmda seletivos para nr2b
TW201819376A (zh) 2016-10-06 2018-06-01 比利時商健生藥品公司 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途

Similar Documents

Publication Publication Date Title
JP2018520170A5 (https=)
HRP20200410T1 (hr) Supstituirani 4-azaindoli i njihova upotreba kao modulatora glun2b receptora
JP2019530695A5 (https=)
JP7308220B2 (ja) オキサジンモノアシルグリセロールリパーゼ(magl)阻害剤
JP2016523911A5 (https=)
JP2011500806A5 (https=)
JP7609854B2 (ja) Magl阻害剤としての4,4a,5,7,8,8a-ヘキサピリド[4,3-b][1,4]オキサジン-3-オン化合物
JP2021533093A (ja) モノアシルグリセロールリパーゼ阻害剤としての新規複素環化合物
JP4638355B2 (ja) チアゾール誘導体
JP2016519156A5 (https=)
JP2017502049A5 (https=)
CN116531380A (zh) 用于治疗癌症的2-杂芳基-3-氧代-2,3-二氢哒嗪-4-甲酰胺
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
CN107624111A (zh) 作为激酶抑制剂的杂环酰胺
CN104024250B (zh) 作为痕量胺相关受体(taar)的杂环衍生物
US9809573B2 (en) Substituted pyridine derivatives useful as GSK-3 inhibitors
JP2019523233A5 (https=)
JP2016523925A5 (https=)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2017500364A5 (https=)
JP2017528515A5 (https=)
RU2016112952A (ru) Производные индола и индазола
JP2020503302A5 (https=)
JP6255516B2 (ja) モルホリン−ピリジン誘導体
KR101898364B1 (ko) 인돌린-2-온 및 1,3-다이하이드로-피롤로[3,2-c]피리딘-2-온 유도체